Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer
Blasco-Benito S, Moreno E, Seijo-Vila M, Tundidor I, Andradas C, Caffarel MM, Caro-Villalobos M, Uriguen L, Diez-Alarcia R, Moreno-Bueno G,…
Inhibition of Wnt/beta-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer
Proto, MC, D Fiore, C Piscopo, S Franceschelli, V Bizzarro, C Laezza, G Lauro, A Feoli, A Tosco, G Bifulco,…